FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

22192002: Salicylamide (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
37255011 Salicylamide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
406001000241113 salicylamide (substance) fr Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)
751572014 Salicylamide (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
839231000172114 salicylamide fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Common French translation module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Salicylamide est un(e) (attribut) Non-steroidal anti-inflammatory agent (substance) true Inferred relationship Some
Salicylamide est un(e) (attribut) Substance with salicylamide structure true Inferred relationship Some
Salicylamide est un(e) (attribut) Salicylate (substance) false Inferred relationship Some
Salicylamide est un(e) (attribut) Salicylate (product) false Inferred relationship Some
Salicylamide est un(e) (attribut) analgésique et antipyrétique false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing benzocaine and salicylamide in cutaneous dose form (medicinal product form) a pour principe actif (attribut) True Salicylamide Inferred relationship Some 1
Acetaminophen- and salicylamide-containing product in oral dose form a pour principe actif (attribut) True Salicylamide Inferred relationship Some 1
Product containing only benzocaine and salicylamide (medicinal product) a pour principe actif (attribut) True Salicylamide Inferred relationship Some 1
Acetaminophen and caffeine and salicylamide only product a pour principe actif (attribut) True Salicylamide Inferred relationship Some 1
Acetaminophen and salicylamide only product a pour principe actif (attribut) True Salicylamide Inferred relationship Some 1
Acetaminophen and phenyltoloxamine and salicylamide only product a pour principe actif (attribut) True Salicylamide Inferred relationship Some 1
Salicylamide only product a pour principe actif (attribut) True Salicylamide Inferred relationship Some 1
Benzocaine and salicylamide only product in cutaneous dose form a pour principe actif (attribut) True Salicylamide Inferred relationship Some 1
Product containing only paracetamol and phenyltoloxamine and salicylamide in oral dose form (medicinal product form) a pour principe actif (attribut) True Salicylamide Inferred relationship Some 1
Acetaminophen and salicylamide only product in oral dose form a pour principe actif (attribut) True Salicylamide Inferred relationship Some 1
Salicylanilide est un(e) (attribut) False Salicylamide Inferred relationship Some
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) Has basis of strength substance (attribute) True Salicylamide Inferred relationship Some 1
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) Has precise active ingredient True Salicylamide Inferred relationship Some 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) True Salicylamide Inferred relationship Some 2
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Salicylamide Inferred relationship Some 2
Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet Has basis of strength substance (attribute) True Salicylamide Inferred relationship Some 2
Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet Has precise active ingredient True Salicylamide Inferred relationship Some 2
Salicylamide measurement élément (attribut) True Salicylamide Inferred relationship Some 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) a pour principe actif (attribut) False Salicylamide Inferred relationship Some
Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet a pour principe actif (attribut) False Salicylamide Inferred relationship Some
Acetaminophen 250 mg and salicylamide 600 mg oral tablet a pour principe actif (attribut) False Salicylamide Inferred relationship Some
Product containing paracetamol and salicylamide (medicinal product) a pour principe actif (attribut) True Salicylamide Inferred relationship Some 1
Acetaminophen + phenyltoloxamine citrate + salicylamide a pour principe actif (attribut) False Salicylamide Inferred relationship Some
Product containing salicylamide (medicinal product) a pour principe actif (attribut) True Salicylamide Inferred relationship Some 1
Product containing caffeine and paracetamol and salicylamide (medicinal product) a pour principe actif (attribut) True Salicylamide Inferred relationship Some 1
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) a pour principe actif (attribut) False Salicylamide Inferred relationship Some
Product containing benzocaine and salicylamide (medicinal product) a pour principe actif (attribut) True Salicylamide Inferred relationship Some 1
Salicylamide measurement Has measured component False Salicylamide Inferred relationship Some
Ethenzamide est un(e) (attribut) False Salicylamide Inferred relationship Some
Acetaminophen 250 mg and salicylamide 600 mg oral tablet Has basis of strength substance (attribute) True Salicylamide Inferred relationship Some 1
Acetaminophen 250 mg and salicylamide 600 mg oral tablet a pour principe actif (attribut) False Salicylamide Inferred relationship Some 2
Acetaminophen 250 mg and salicylamide 600 mg oral tablet Has basis of strength substance (attribute) False Salicylamide Inferred relationship Some 2
Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet a pour principe actif (attribut) False Salicylamide Inferred relationship Some 1
Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet Has basis of strength substance (attribute) False Salicylamide Inferred relationship Some 1
Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet Has basis of strength substance (attribute) False Salicylamide Inferred relationship Some 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) a pour principe actif (attribut) False Salicylamide Inferred relationship Some 3
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance (attribute) False Salicylamide Inferred relationship Some 3
Acetaminophen 250 mg and salicylamide 600 mg oral tablet Has precise active ingredient True Salicylamide Inferred relationship Some 1
Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient False Salicylamide Inferred relationship Some 3
Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet Has precise active ingredient False Salicylamide Inferred relationship Some 3
Acetaminophen- and phenyltoloxamine- and salicylamide-containing product in oral dose form a pour principe actif (attribut) True Salicylamide Inferred relationship Some 1
Product containing paracetamol and phenyltoloxamine and salicylamide (medicinal product) a pour principe actif (attribut) True Salicylamide Inferred relationship Some 1
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) Has precise active ingredient False Salicylamide Inferred relationship Some 2
Product containing precisely benzocaine 20 milligram/1 gram and salicylamide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) Has basis of strength substance (attribute) False Salicylamide Inferred relationship Some 2

This concept is not in any reference sets

Back to Start